Funding, deals, hiring, trials and approvals across biotech, pharma and academia — plus the newest papers in virology, molecular biology, cell biology, NGS, oncology and veterinary medicine, ranked by journal tier and topical fit.
A standing roster of biopharma and life-science tooling companies — 18 tracked.
Merck Highlights Landmark Gilvetmab Research in Canine Cancer Treatment
Global Agriculture · 2026-10-10
24/7 Market News Highlights NeOnc, Revolution Medicines, Moderna, Merck, Johnson & Johnson and Genmab, AbbVie in 2026 Cancer Treatment Advances
Quiver Quantitative · 2026-10-07
Pfizer to cut around 330 jobs in Italy
pharma.economictimes.indiatimes.com · 2026-10-08
Pfizer (PFE) Could Be 3% Below Fair Value After Fresh TUKYSA FDA Approval
Yahoo Finance · 2026-10-08
FDA approves Pfizer’s Tukysa regimen for metastatic breast cancer
Yahoo Finance · 2026-10-08
Quantum BioPharma (QNTM) Enlists Thermo Fisher's Clinical Research Business to Launch Phase 2 Lucid-MS Trial
Yahoo Finance · 2026-10-07
Quantum BioPharma Signs Contract with Thermo Fisher
GlobeNewswire · 2026-10-06
Novartis' Rhapsido gains new FDA approval
The Pharma Letter · 2026-10-08
Novartis-partnered biotech nabs $150M Series B to move into the clinic
Endpoints News · 2026-10-07
Novartis Rhapsido® (remibrutinib) receives FDA approval as
GlobeNewswire · 2026-10-07
24/7 Market News Highlights NeOnc, Revolution Medicines, Moderna, Merck, Johnson & Johnson and Genmab, AbbVie in 2026 Cancer Treatment Advances
Quiver Quantitative · 2026-10-07
Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elahere
Fierce Biotech · 2026-10-05
Rocket Pharmaceuticals Highlights FDA-Aligned Pivotal Phase 2 Trial and Updated Clinical Findings for RP-A501 Following Danon Disease Investor Webinar
Business Wire · 2026-10-07
Also watching, nothing this window: Azenta Life Sciences, Humane Genomics, Boehringer Ingelheim, Lexeo Therapeutics, Regeneron, GenScript, UCB, Immunai, Insmed, Mount Sinai, Evotec, Kenvue
Highest-scoring work indexed this window, one per field.
| Virology | |
| Molecular Biology | |
| Cell Biology | |
| NGS / Genomics | |
| Oncology | |
| Veterinary Medicine |
Ordered by how many independent outlets ran the story
FDA Approves Tecentriq Plus Chemotherapy for Stage III Mismatch Repair-Deficient Colon Cancer BioPharm International
FDA approves Pfizer’s Tukysa regimen for metastatic breast cancer Pharmaceutical Business review -
FDA approves Roche’s Tecentriq immunotherapy combination for dMMR colon cancer European Pharmaceutical Review
FDA Approves Remibrutinib for Treatment-Resistant Symptomatic Dermographism Specialty Pharmacy Continuum
PMV Pharma appoints Matt Eckler to board of directors By Investing.com Investing.com UK
FDA Approves Tukysa Plus Trastuzumab and Pertuzumab as First-Line Maintenance Treatment for HER2-Positive Metastatic Breast Cancer Pharmaceutical Executive
One Health Innovation District Breaks Ground on One Health Research Institute, Anchored by Purdue University and Elanco Animal Health CSRwire
Israeli Pharma Giant Teva Wins FDA Approval for Monthly Schizophrenia Injection Weltruza Haaretz
Highlighting the FDA Approval of Maintenance Tucatinib-Based Therapy in Advanced HER2+ Breast Cancer OncLive
Shionogi continues rare disease expansion with acquisition of IntraBio The Pharma Letter
Financings, IPOs, venture rounds
Neela Biotech raises £2.1M to turn waste into aviation fuel Dealroom
City Therapeutics eyes valuation of up to $956.3 million in US IPO amid biotech listing push Yahoo Finance
IPO News - US IPO Weekly Recap: Biotech IPOs keep flowing as data center developer DayOne joins the pipeline Renaissance Capital
Forbion, a prominent biotech investor, raises $2.6B for a pair of venture funds BioPharma Dive
TRex Bio stomps toward $111M IPO, as Retension and Lycia also gear up to go public Fierce Biotech
M&A, licensing, reverse mergers
Shionogi strikes $2B deal for IntraBio hot off FDA label expansion Fierce Pharma
CAR-T biotech Caribou makes ‘heartbreaking’ call to shrink headcount, halt pipeline Fierce Biotech
In the hunt for reverse merger targets, Caribou could be prized game BioPharma Dive
Argenx digests phase 2 celiac win for $2.2B drug, preps pivotal run Fierce Biotech
Viatris to snap up Pacira's non-opioid pain pipeline for $1.65B Fierce Pharma
Hires, exits, layoffs, restructurings
Zeon Lifesciences Appoints Dr. Sundeep Talwar as Chief Executive Officer CXO Movements
Biotech layoffs in Q3 hit over 440 Massachusetts workers NBC Boston
Eris Lifesciences appoints Chirag Mehta as Executive Director Indian Pharma Post
Big Pharma-backed Nuvig halts development of lead fusion protein in rare autoimmune disease Fierce Biotech
Fierce Biotech Layoff Tracker 2026: Caribou cuts staff, halts pipeline; Foghorn reduces workforce by 40% Fierce Biotech
Readouts, starts, failures
SYCUME meets primary endpoint in Phase 3 trial for inactive thyroid eye disease The Clinical Trial Vanguard
Front Range Pharmaceuticals Announces FDA Clearance to Initiate Phase 2 Trial of FRP-003 in Long COVID Business Wire
Quantum BioPharma (QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial Yahoo Finance
Rezera Announces Positive RESOLVE-2 Phase 2 Clinical Trial GlobeNewswire
First Patient Dosed in Phase 2a Trial of GlyphAgo for Generalized Anxiety Disorder and Sleep Disturbance Psychiatric Times
Approvals, CRLs, CHMP opinions
FDA Approves IV, Subcutaneous Atezolizumab for dMMR Colon Cancer AJMC
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia The American Journal of Managed Care
Roche Gets FDA Approval for Another Label Expansion of Tecentriq Yahoo Finance
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia Patient Care Online
Polymeric nanomedicines reprogram the tumor microenvironment to turn cold tumors hot The Des Moines Register
Grants, budgets, institutions
NIH Awards BU Clinical & Translational Science Institute $41 Million in New Funding | The Brink Boston University
WT receives $9.75M USDA grant for cattle feedlot research facility KVII
University of Cincinnati researcher to launch national study with $2.5M NIH grant The Business Journals
US appeals court weighs Trump's block on Harvard research funding Reuters
NGS, virology and animal-health industry moves
10x Genomics, Fred Hutch Launch Cancer Diagnostics Research Collaboration Clinical Lab Products
Elanco Animal Health Incorporated (ELAN) Stock Price, News & Analysis Stock Titan
Illumina's Clinical Sequencing Revenue Seen as Durable Mid-Teens Grower, RBC Capital Markets Says Yahoo Finance
Trump: U.S. willing to help Russia with potential pneumonic plague outbreak Axios
Dozens quarantined in Russia after death at plague lab Nine.com.au
4 issues published.